Related Experiment Video
Updated: Nov 28, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is
Stacey Bartlett1, Adrian Tandhyka Gemiarto1, Minh Dao Ngo1
1Translational Research Institute-Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Abstract:
Oxidized cholesterols have emerged as important signaling molecules of immune function, but little is known about the role of these oxysterols during mycobacterial infections. We found that expression of the oxysterol-receptor GPR183 was reduced in blood from patients with tuberculosis (TB) and type 2 diabetes (T2D) compared to TB patients without T2D and was associated with TB disease severity on chest x-ray. GPR183 activation by 7α,25-dihydroxycholesterol (7α,25-OHC) reduced growth of Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis BCG in primary human monocytes, an effect abrogated by the GPR183 antagonist GSK682753. Growth inhibition was associated with reduced IFN-β and IL-10 expression and enhanced autophagy. Mice lacking GPR183 had significantly increased lung Mtb burden and dysregulated IFNs during early infection. Together, our data demonstrate that GPR183 is an important regulator of intracellular mycobacterial growth and interferons during mycobacterial infection.
Insights
The oxysterol receptor GPR183 plays a key role in controlling mycobacterial infections. Activating GPR183 inhibits the growth of Mycobacterium tuberculosis, offering a potential therapeutic target for tuberculosis.
Area of Science:
- Immunology
- Infectious Diseases
- Molecular Biology
Background:
- Oxidized cholesterols (oxysterols) are crucial immune signaling molecules.
- The role of oxysterols in mycobacterial infections, particularly tuberculosis (TB), remains largely unexplored.
Purpose of the Study:
- To investigate the role of the oxysterol receptor GPR183 in mycobacterial infections.
- To determine the impact of GPR183 on the growth of Mycobacterium tuberculosis (Mtb) and host immune responses.
Main Methods:
- Quantified GPR183 expression in patients with TB and type 2 diabetes (T2D).
- Assessed the effect of GPR183 activation (using 7α,25-dihydroxycholesterol) and antagonism on Mtb and Mycobacterium bovis BCG growth in human monocytes.
- Analyzed cytokine expression (IFN-β, IL-10) and autophagy.
- Studied Mtb infection in GPR183-deficient mice.
Main Results:
- Reduced GPR183 expression was observed in patients with TB and T2D, correlating with TB severity.
- GPR183 activation inhibited Mtb and BCG growth in human monocytes, an effect blocked by a GPR183 antagonist.
- Inhibition of mycobacterial growth was linked to decreased IFN-β and IL-10 and enhanced autophagy.
- GPR183-deficient mice exhibited increased lung Mtb burden and disrupted interferon responses during early infection.
Conclusions:
- GPR183 is a critical regulator of intracellular mycobacterial growth.
- GPR183 influences host interferon responses during mycobacterial infection.
- Targeting GPR183 may represent a novel therapeutic strategy for managing mycobacterial infections.
Related Concept Videos
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Stringent Response in E. coli
Activation and Inactivation of G Proteins
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

